Evidence map›Paper›PMID 31758412›Full record

ArticleJournal of industrial microbiology & biotechnology2020

Engineering a newly isolated Bacillus licheniformis strain for the production of (2R,3R)-butanediol.

Chan Woo Song, Rathnasingh Chelladurai, Jong Myoung Park, Hyohak Song

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chan Woo SongResearch and Development Center, GS Caltex Corporation, Yuseong-gu, Daejeon, 34122, Republic of Korea.
Rathnasingh ChelladuraiResearch and Development Center, GS Caltex Corporation, Yuseong-gu, Daejeon, 34122, Republic of Korea.
Jong Myoung ParkResearch and Development Center, GS Caltex Corporation, Yuseong-gu, Daejeon, 34122, Republic of Korea.
Hyohak SongResearch and Development Center, GS Caltex Corporation, Yuseong-gu, Daejeon, 34122, Republic of Korea. hyohaks@gscaltex.com.ORCID http://orcid.org/0000-0001-7376-6355

Funding

Korea Evaluation Institute of Industrial Technology No. 10050407
6 · The paper itself

Abstract

Several microorganisms can produce 2,3-butanediol (BDO), an industrially promising chemical. In this study, a Bacillus licheniformis named as 4071, was isolated from soil sample. It is a GRAS (generally recognized as safe) strain and could over-produce 2,3-BDO. Due to its mucoid forming characteristics, UV-random mutagenesis was carried out to obtain a mucoid-free strain, 4071-15. As a result, capabilities of 4071-15 strain in terms of transformation efficiency of bacillus plasmids (pC194, pUB110, and pUCB129) and fermentation performance were highly upgraded compared to those of the parent strain. In particular, 4071-15 strain could produce 123 g/L of 2,3-BDO in a fed-batch fermentation in which the ratio of (2R,3S)- to (2R,3R)-form isomers was 1:1. To increase the selectivity of (2R,3R)-BDO, budC gene was deleted by using temperature-sensitive gene deletion process via homologous recombination. The 4071-15 △budC mutant strain dramatically increased selectivity of (2R,3R)-BDO to 91% [96.3 g/L of (2R,3R)-BDO and 9.33 g/L of (2R,3S)-BDO], which was 43% higher than that obtained by the parent strain. This study has shown the potential of an isolate for 2,3-BDO production, and that the ratio of 2,3-BDO can be controlled by genetic engineering depending on its industrial usage.

Indexed as

Bacillus licheniformisButylene GlycolsFermentationMetabolic EngineeringMutationPhylogenyButylene Glycols2,3-ButanediolBacillus licheniformisFermentationIsolationSelectivity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.